GlaxoSmithKline Buys Canadian Drugmaker For $950M
GSK PLC said Wednesday that it has agreed to pay $950 million in cash for Canadian clinical-stage drugmaker 35Pharma Inc., which is developing a medicine to treat a type of high...To view the full article, register now.
Already a subscriber? Click here to view full article